Vitamin D status and oxidative stress markers in the elderly with impaired fasting glucose and type 2 diabetes mellitus

Aging Clinical and Experimental Research

Volumn 24, Issue 6, 2012, Pages 595-602

  Gradinaru, Daniela ^a,b   Borsa, Claudia ^a   Ionescu, Cristina ^a   Margina, Denisa ^b   Prada, Gabriel I ^a,b   Jansen, Eugène ^c  

^a National Institute of Gerontology and Geriatrics   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ADVANCED GLYCATION END PRODUCT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; VITAMIN D;

AGED; AGING; ARTICLE; CARDIOVASCULAR RISK; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LIPID BLOOD LEVEL; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION KINETICS; OXIDATIVE STRESS; VITAMIN D DEFICIENCY;

AGED; AGING; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE METABOLISM DISORDERS; HUMANS; LIPIDS; MALE; OXIDATIVE STRESS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84876926149     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.3275/8591     Document Type: Article

References (31)

1. Anderson JL, May HT, Horne BD et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010; 106: 963-8.
2. Parker J, Hashmi O, Dutton D et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010; 65: 225-36.
3. Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am 2010; 39: 419-46.
4. Alvarez JA, Ashraf A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010; 351385. Available at http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC2778451/ Accessed December 21, 2011.
5. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 2011; 65: 1005-15.
6. Beauchet O, Hélard L, Montero-Odasso M, de Decker L, Berrut G, Annweiler C. Hypovitaminosis D in geriatric inpatients: a marker of severity of chronic diseases. Aging Clin Exp Res 2011; 24:188-92.
7. Semba RD, Houston DK, Bandinelli S. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 2010; 64: 203-9.
8. Barengolts E. Vitamin D role and use in prediabetes. Endocr Pract 2010; 16: 476-85.
9. Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011; 94: 486-94.
10. Naharci I, Bozoglu E, Kocak N, Doganci S, Doruk H, Serdar M. Effect of vitamin D on insulin sensitivity in elderly patients with impaired fasting glucose. Geriatr Gerontol Int 2012: 12: 454-60.
11. Tabak O, Gelisgen R, Erman H et al. Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. Clin Invest Med 2011; 34: E163-71.
12. Piwowar A, Knapik-Kordecka M, Warwas M. Markers of oxidative protein damage in plasma and urine of type 2 diabetic patients. Br J Biomed Sci 2009; 66: 194-9.
13. Pitocco D, Zaccardi F, Di Stasio E et al. Oxidative stress, nitric oxide, and diabetes, Rev Diab Stud 2010; 1: 15-5.
14. Shea MK, Booth SL, Massaro JM et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2008; 167: 313-20. (Pubitemid 351197593)
15. Tarcin O, Yavuz DG, Ozben B et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009; 94: 4023-30.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34: 562-69.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9. (Pubitemid 15018832)
18. Scoccia AE, Molinuevo MS, McCarthy AD, Cortizo AM. A simple method to assess the oxidative susceptibility of low density lipoproteins. BMC Clin Pathol 2001; 1:1. Available at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC34102. Accessed September 21, 2011.
19. Bartling B, Hofmann HS, Sohst A et al. Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end-products in non-small cell lung carcinoma. Mol Med 2011; 17: 980-9.
20. Dobiásová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem 2001; 34: 583-8. (Pubitemid 34014853)
21. Riek AE, Oh J, Bernal-Mizrachi C. Vitamin D regulates macrophage cholesterol metabolism in diabetes. J Steroid Biochem Mol Biol 2010; 121: 430-3.
22. Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving HH, Rossing P. Vitamin D levels and mortality in type 2 diabetes. Diabetes Care 2010; 33: 2238-43.
23. Reis AF, Hauache OM, Velho G. Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes Metab 2005; 31: 318-25. (Pubitemid 41391473)
24. Pan HZ, Zhang L, Guo MY et al. The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol 2010; 47: 71-76.
25. Targher G, Bertolini L, Padovani R et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006; 65: 593-7. (Pubitemid 44583818)
26. Tanaka M, Tokunaga K, Komaba H et al. Vitamin D receptor activator reduces oxidative stress in hemodialysis patients with secondary hyperparathyroidism. Ther Apher Dial 2011; 15: 161-8.
27. Wiseman H. Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. FEBS Lett 1993; 326: 285-8. (Pubitemid 23200295)
28. Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 2011; 50: 303-12.
29. Ghasemi A, Zahediasl S, Azimzadeh I, Azizi F. Increased serum nitric oxide metabolites in dysglycaemia. Ann Hum Biol 2011; 38: 577-82.
30. Borsa C, Ionescu C, Gradinaru D. Oxidized LDL and NO synthesis as biomarkers of atherogenesis. Correlations with metabolic profile in elderly. In Parthasarathy S, Ed. Atherogenesis. InTech Open Access Publisher 2011, 473-94. Available at: http://www.intechopen.com/articles/show/title/oxidized-ldl-and-no- synthesis-as-biomarkers-of-atherogenesis-correlations-with-metabolic-profile-in- .
31. Muscogiuri G, Sorice GP, Ajjan R et al. Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutr Metab Cardiovasc Dis 2012; 22: 81.